Abstract. We report that a E1 integrin (o~5fll) can exist in different affinity states for its soluble ligand, fibronectin. The ot5fll expressed by the erythroleukemic cell line K562 binds soluble fibronectin with low affinity (Ka > 1 #M), but is induced to bind it with 20-fold higher affinity in the presence of the anti-ill mAb 8A2. This activation seems to be due to direct antibody-induced change in the receptor that does not require intracellular signaling, and is a plausible basis for the 8A2-induced enhancement of ill-dependent adhesion to fibronectin and other immobilized ligands (Kovach, N. L., T. M. Carlos, E. Yee, and J. M. Harlan. 1992. J. Cell BioL 116: 499-509). Fab fragments of 8A2 bind with higher affinity to ot5fll receptor that is occupied by the GRG-DSP peptide ligand suggesting that the antibody functions by stabilizing a high affinity (occupied) conformer of the receptor. A functional consequence of the affinity modulation is that soluble fibronectin (at physiological concentrations) occupies the high affinity receptors, and so becomes an effective inhibitor of adhesion to immobilized fibronectin. In contrast, the majority of low affinity receptors remain unoccupied and are still able to mediate cellular adhesion. C eLL adhesion is controlled by interactions between adhesion receptors and their ligands. Changing the repertoire of adhesive receptors, by either modifying biosynthetic patterns (16, 39, 45, 47) or by receptor translocations (8, 35) , are strategies to modify cell adhesion. The function of adhesion receptors can also be changed by structural alterations, by changes in mRNA splicing (5, 10, 30, 41, 54) , proteolytic cleavage (31), or variations in glycosylation (17). Finally, cellular adhesion can be rapidly regulated through reversible modulation of receptor function, and this mechanism is a key feature of the integrin family of adhesion receptors (4, 15, 42, 51, 52) .
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The most widespread integrins are the/31 subfamily (VLA family) (27) (28) (29) , and there is dynamic regulation of fll integrin-mediated adhesion. T lymphocytes and T lymphoid cell lines, activated either with phorbol esters, by crosslinking CD3, or with activating combinations of anti-CD2 mAbs, exhibit increased ill-dependent adhesion to immobilized ligands (51, 52) . This occurs without alterations in their repertoire of integrins. Cellular adhesion to immobilized ligand is a complex multi-step process, involving initial receptor-ligand interaction, followed by strengthening of adhesion through organization of the cytoskeleton, focal contact formation, and cell spreading (11, 55) . Cells could enhance adhesion by the facilitation of any of these steps. For example, Danilov et al. (14) found that phorbol esters enhanced the adhesion of CHO cells to immobilized fibronectin without any detectable change in the affinity of their fibronectin receptors for soluble ligand. Alternatively, the ligand binding affinity of certain integrins can be rapidly altered. For example, platelet receptor allbfl3 (or GPIIbHIa) exists in at least two affinity states for its soluble ligand, fibrinogen (7, 33, 50) , which appear to be a result of different conformations of the receptor (13, 40) . Conversion from low to high affinity binding of fibrinogen can be induced by treating the platelets with agonists such as phorbol esters, ADP, and thrombin (43, 44) , and by certain mAbs directed against the f13 chain (40). Interconversion between low and high affinity fihrinogen binding states also occurs with otMff2 (4). Direct demonstration of affinity modulation of fll integrins has not been reported. However, it is known that soluble fibronectin binds with moderate affinity to E1 integrins expressed by cell lines such as CliO cells (K~ = 100 nM) (14) and BHK cells (Kd = 800 riM) (1) .
Several anti-B1 mABs which enhance/31 integrin-dependent cellular adhesion have been described (6, 32, 38, 53) . In this paper we have used one of these antibodies (8A2, reference 32), to investigate affinity modulation of the fibronectin receptor, ot5fll. We show that the a5fll expressed by the erythroleukemic cell line K562 binds soluble fibronectin with low affinity which can be increased 20-fold by 8A2. The alteration in affinity occurs in the presence of inhibitors of intracellular signaling, and it appears that the antibody functions by directly inducing a high affinity conformation of the receptor. Finally, the biologic consequences of affinity modulation of a5B1 were found to depend on the ambient soluble fibronectin concentration.
Materials and Methods

Antibodies and Reagents
Production and initial characterization of the murine anti-human/31 mAb 8A2 (IgGl-r isotype) has been described (32) . The rat anti-human ~5 mAb BIIG2 and rat anti-human/~1 mAb AIIB2 (23) were used as dilutions of ascites. The murine anti-human a4 mAb HP2/1 (49) was used as dilutions of tissue culture supernatant. The murine anti-human/~1 mAbs AlAS and TS2/16 (25) were used as dilutions of ascites. The murine anti-human fibronectin mAb Fnl.ll was produced in our laboratory as described (9) , and used as dilutions of ascites. The murine anti-human HLA class I mAb W6/32 was obtained from the American Type Culture Collection (Rockville, MD) and used as dilutions of purified IgG. The peptide GRGDSP was obtained from Peninsula Laboratories (Belmont, CA) and the peptide GRGESP was synthesized in the Scripps Research Institute core facility (La Jolla, CA). Glucose and 2-deoxyglucose were purchased from Sigma (St. Louis, MO) and sodium azide from Fisher Scientific Co. (Pittsburgh, PA).
Cells
The erythroleukemic cell line K562 was obtained from the ATCC, and was maintained in RPMI medium (Biowhittaker, Walkersville, MD) supplemented with 10% FCS (Biowhittaker), 1% glntamine (Sigma), and 1% penicillin and 1% streptomycin (Sigma). U937, Jurkat (both from ATCC), and Molt-13 (from Dr. Dario Altieri, The Scripps Research Institute) cells were maintained in the same medium. THP-1 cells (from the ATCC) were maintained in this medium with the addition of 10 mM Hepes and 20 mM 2-mercaptoethanol. Human T lymphocytes were purified from the peripheral blood of normal donors by centrifugation on a Ficoll-Paque gradient (Pharmacia Fine Chemical, Piscataway, N J), panning for monocytes on serum-coated dishes, and passaging over a nylon wool column.
Purification of SA2 IgG and Fab Fragments
8A2 whole IgG was purified from ascites by binding to protein A immobilized on sepharose beads (Pharmacia LKB, Uppsala, Sweden). The antibody was incubated with the protein A-sepharose under high salt conditions (3.3 M NaCI and 0.5 M Na borate, pH 8.9), and eluted with 100 mM glycine, pH 3.0 into tubes containing L0 M Tris, pH 8.0. The peak fractions were pooled and dialyzed overnight against PBS. Fab fragments were produced by overnight incubation of the purified 8A2 IgG with papain crosslinked to beaded agarose (Pierce Chemical Co., Rockford, IL), according to the manufacturer's instructions. After removal of the immobilized papain by centrifugation, the supernatant was passed over a protein A-sepharose column, and the non-binding fraction analyzed for purity of the Fab fragments by SDS-PAGE under non-reducing conditions. Densitometry confirmed that <2% of the 8A2 Fab preparation remained in the form of intact IgG. The concentration of purified IgG and Fab fragments was determined by absorbance at 280 nm (1 OD = 0.8 mg/mi) (24) .
Purification of Human Fibronectin
Fibronectin was isolated from fresh human citrated plasma by affinity chromatography on gelatin-sephamse (Pharmacia Fine Chemical), as we have previously described (42) . The isolated fibronectin yielded a single band on SDS-PAGE under non-reducing conditions, and a closely spaced doublet of 215,000 and 230000 D under reducing conditions, consistent with the reported properties of plasma fibronectin (12) . The concentration of fibronectin was determined by absorbance at 280 nM v~0. 1~A2s°m = 1.3) (36).
Radiolabeling of Fibronectin and 8A2 Fab Fragments
The fibronectin was labeled with 125Iodine by a modified Chloramine-T procedure, as described (42) . The 8A2 Fab fragments were radiolabeled by the same Chloramine-T method, the sample run over a PDI0 Sephadex column (Pharmacia Fine Chemicals), and the peak activity fractions pooled. Greater than 90% of the radioactivity was precipitated by 10% TCA. Aliquots were stored at -70°C following the addition of BSA to 1% final concentration.
Binding Assays
Assays of the binding of ~2SI-labeled fibronectin and 8A2 Fab fragments were based on assays of fibronectin binding to platelets that we have previously described (42) . The standard buffer used in the assays was modified Tyrode's buffer (150 mM NaCI, 2.5 mM KC1, 12 mM NaHCO3, 1 mg/ml BSA, 1 mg/ml glucose, and 2 mM MgC12), pH 7.4. Cells were washed twice in the appropriate buffer before being suspended in the same at the indicated density. The incubation time was typically 30 min at room temperature, as pilot studies showed that >90 % of the maximal fibronectin binding occurred by this time. A typical binding assay, performed in a 1.5-mi microcentrifuge tube (Sarstedt, Germany), was in a 200-/~1 vol composed of 120 /~1 of cells (2 x l0 s per tube), 40 /~1 of radiolabcled protein (fibroncctin or 8A2), and 40/~1 of stimulus (e.g., cold 8A2) and/or inhibitor (e.g., EDTA, mAb, GRGDSP). After the incubation, 50-#1 aliquots were layered in triplicate onto 300 Izl of 20% sucrose in the same buffer in microfuge tubes (West Coast Scientific Inc., Hayward, CA), and centrifuged for 3 min at 12,000 rpm in a microfuge (Beckman Instruments, Fullerton, CA). The tips were amputated and counted, and the bound protein was calculated from the specific activity of the ligand (assuming a molecular weight offibronectin as 440,000 and 8A2 Fab fragments as 50000 D). For fibronectin binding, the residual bound radioactivity in the presence of 5 mM EDTA was subtracted as non-specific binding (i.e., non-integrindependent binding). The bound fibronectin did not undergo detectable pmteolytic degradation or transglutaminase-mediated cross-linking during these experiments, as the bound fibronectin subunits showed identical mobility to input subunlts on reduced SDS gels. Reversibility of the fibronectin binding was established in control experiments where EDTA was added to the mixture of cells and radiolabeled fibronectin 30 min after the commencement of the incubation. Greater than 90 % of the radiolabel was eluted from the cells after 90 rain of incubation with the EDTA. For 8A2 Fab fragments, the non-specific binding was determined in the presence of a 50x excess of cold 8A2 IgG. The data was fitted to equilibrium binding models using the LIGAND program (37) .
Assays of Cell Adhesion to Immobilized Fibronectin
The assay of K562 adhesion to immobilized fibronectin were based on that described by Prater et al. (46) . Fibronectin was diluted in PBS, pH 7.4, and 50-/~1 aliquots incubated in the wells of a 96-well Immulon H plate (Dynatech Laboratories Inc., Chantilly, VA) for 2 h at 37°C. After washing with PBS, the wells were blocked with 1% BSA in PBS for 1 h at 37"C. The buffer used in the adhesion assay was the same as in the binding assays. Cells were washed twice in this buffer, resuspended at 1 x 106 cells/ml, and 100-/~1 aliquots added to the emptied wells. Where required, appropriate concentrations of stimulus or inhibitor (e.g., antibody EDTA) were mixed with the cells when they were added to the wells, except in assays involving soluble fibronectin. In this case, the cells were preincubated with antibody (8A2 or W6/32) and soluble fibronectin for 30 min rocking at room temperature, before addition to the wells. After a 30-rain incubation at room temperature, the non-adherent cells were washed off with three rounds of gentle pipetting. The residual adherent cells were checked by visual inspection, and quantified with a colorimetric reaction using endogenous cellular acid phosphatase activity by adding 100 #1 of the following substrate/lysis solution to each well: 1% Triton X-100 (Fisher Scientific Co.), 6 mg/ml p-nitrophenylphosphate (Sigma), in 50 mM sodium acetate buffer, pH 5.0. After a 1-h incubation at 37°C, the reaction was terminated by the addition of 50/~1 of 1 M NaOH, and read in an ELISA plate reader (Molecular Devices Corp., Menlo Park, CA) with a 410 nm filter. Background values, determined in wells coated with 1% BSA alone, were subtracted from each point. Adherence was expressed as a percentage of the number of cells originally added to each well, and determined from a standard curve generated using known numbers of cells.
Results
~5~ I on Nonadherent Cells Binds Little Soluble Fibronectin
As noted in the introduction, at least two adherent cell lines (1, 14) express t~5/31 that binds soluble fibronectin with moderate affinity. To investigate the affinity state of ct5~l on cells that grow in suspension, we assessed fibronectin binding to the K562 erythroleukemic cell line. These cells were chosen because they express only o~5fll of the 81 integrins, and do not express/93 integrins without induction (26) . In contrast to BHK or CHO cells (1, 14) , very little binding of soluble fibronectin to the K562 cells was observed (Fig. 1) . Nevertheless, the cx5/~l on these cells had the potential to bind substantial soluble fibronectin in the presence of the monoclonal antibody 8A2. The 8A2-induced binding was completely inhibited by a blocking antibody against the or5 chain ( Fig. 1) , confirming that a5fll was responsible for all the observed binding. Moreover, it was mediated by the "classical" cell binding site in fibronectin, as it was blocked by a monoclonal anti-fibronectin antibody that recognizes this site (9) , and by an RGD-but not an RGE-containing peptide (Fig. 1) . Consistent with integrin-mediated binding, it were obtained with the monocytic cell lines THP-1 and U937, and the lymphoid cell lines Jurkat and Molt-13 (data not shown). In addition, peripheral blood T lymphocytes also manifested little basal fibronectin binding, and an increased in the presence of 8A2 (Table I) . The binding of fibronectin to K562 cells in response to varying concentrations of 8A2 has been quantified (Fig. 2) . Fibronectin binding approached saturation at above 4 nM of 8A2 IgG, and the EC50 was ,ol.0 riM. Specificity of this effect was documented by the failure of another anti-/31 mAb (AIIB2, reference 23) or an irrelevant antibody (W6/32-anti-HLA class I) to induce this response (data not shown). Moreover, purified Fab fragments of 8A2 were also able to induce fibronectin binding (Fig. 2) , albeit with lower efficiency than intact IgG. The contaminating whole IgG in the Fab preparation could account for <10% of this activity. Thus, the 8A2 effect was not dependent on bivalency nor on the Fc portion of the antibody molecule.
In additional experiments, the mAbs A1A5 and TS2/16, which also stimulate cellular adhesion to immobilized extracellular matrix proteins (6, 53), were able to induce the binding of soluble fibronectin to K562 cells (results not shown).
AJfinity Modulation of c~5~ l
To characterize the mechanism of the increase in fibronectin binding induced by 8A2, detailed equilibrium binding isotherms were analyzed. In the absence of 8A2 there was little binding of fibronectin, although at higher fibronectin concentrations some specific binding was observed (Fig. 3) . (Fig. 3) . The 20-fold difference in receptor affinity observed in the presence of 8A2 was highly significant by constrained parameter (37) curve fitting (F = 63.4, df = 21, P < 0.0001). In sharp contrast, the twofold difference in estimated receptor number was not significant (F = 1.7, df = 21, P = 0.22). Thus, the 8A2 antibody changes the binding affinity of ot5/31 for fibronectin, and/31 integrins, like/32 and/33 integrins, can undergo affinity modulation.
Mechanism of Afflnity Modulation by &42
Active cellular responses have been implicated in the capacivy of anti-~'l monoclonal antibodies to promote cell adhesion (6, 32, 53) , suggesting that these antibodies might work by activating intracellular signaling systems. However, in sharp contrast to previous results, the 8A2-induced increase in fibronectin binding was not affected by the metabolic inhibitors sodium azide and 2-deoxyglucose (Fig. 4 a) . The effect of these drugs on the K562 cells was documented in concurrent measurements of cellular adhesion to immobilized fibronectin (Fig. 4 b) . The metabolic inhibitors profoundly suppressed basal adhesion to fibronectin. Nevertheless, 8A2 promoted similar increases in adhesion in the presence of absence of the inhibitors. Thus, the combination of the inhibitors suppressed a5/31-dependent cellular adbe- sion to fibronectin without affecting the affinity of the fibronectin-integrin interaction. In addition, treating the cells with 0.02 #g/ml of cytochalasin D did not reduce 8A2-induced fibronectin binding even though it effectively blocked basal cell adhesion to immobilized fibronectin (data not shown).
We also examined the relationship between the binding of 8A2 and fibronectin to K562 cells. To do this we simultaneously measured the binding to K562 cells of 50 nM of radiolabeled fibronectin and varying doses of radiolabeled 8A2 Fab fragments. As the concentration of 8A2 Fab increased, the binding of 8A2 Fab fragments (cf. Fig. 6 b) and fibronectin (cf. Fig. 2 ) approached saturation. Replotting of this data as 8A2 bound versus fibronectin bound showed a remarkable correlation between the number of 8A2 molecules bound and the number of high affinity (~5/31 fibronectin receptors, i.e., the number of fibronectin molecules bound (r = 0.995) (Fig.  5 ). This suggests that only those 0t5/31 molecules that have physically associated with 8A2 bind fibronectin with high affinity.
Taken together, the lack of energy requirement and direct nature of the effect of 8A2 suggests that it binds ot5/31 and directly promotes an increase in ligand binding affinity through a change in receptor conformation. To determine whether 8A2 also preferentially recognizes an occupied conformer of a5/31, the binding of 8A2 Fab fragments to K562 cells was quantitated in the presence or absence of the GRGDSP peptide ligand. The addition of increasing concentrations of GRGDSP resulted in a progressive increase in the binding of 10 nM 8A2 Fabs (Fig. 6 a) . The EC50 for this effect was 7.0 #M, which is similar to the IC50 we determined for the inhibition of 8A2-induced fibronectin binding to K562 cells (5.5 #M, data not shown). To define the basis for this effect, the binding of 8A2 Fab fragments to K562 cells in the presence or absence of 200 #M GRGDSP was analyzed (Fig. 6 b) . In the presence of GRGDSP there was an approximate twofold increase in the affinity of 8A2 binding (Ka = 5.5 [+ 0.7] x 107 M -1 to ga = 10.5 [-I-2.0] x 107 M-l), which was statistically significant (F = 6.8, df = 28, P = 0.015). In contrast, the receptor concentration (3.1 to 3.0 nM) was not significantly different in the presence of the peptide (F = 0.2, df = 28, P = 0.65). Thus, ligand binding to the ot5~l increases the affinity of 8A2 binding.
Binding Affinity Governs the Inhibition of CeUular Adhesion by Soluble l~bronectin
Although soluble fibronectin and fibronectin fragments inhibit the adhesion of some cells to immobilized fibronectin (2, 56) , other workers have failed to observe this dualistic role for fibronectin (22) . We examined the possibility that affinity modulation of ot5/31 alters the capacity of soluble fibronectin to block cell adhesion. K562 cells were incubated with either an irrelevant antibody (W6/32) or 100 nM of8A2 IgG in the presence or absence of 675 nM of soluble fibronectin, and permitted to adhere to immobilized fibronectin. Soluble fibronectin modestly (•50 %) inhibited the low basal adhesion of K562 cells (Fig. 7) . As expected, 8A2 nearly tripled adhesion to immobilized fibronectin. Strikingly, the addition of physiological plasma levels of soluble fibronectin (450-900 nM; 1, 36), in the presence of 8A2, completely suppressed specific adhesion to fibronectin. In the presence of soluble fibronectin, the net effect of the 8A2 antibody was profound inhibition of cell adhesion. Thus, the functional consequences of affinity modulation of a5/31 are influenced by the ambient concentration of soluble fibronectin.
Discussion
The most important findings in this work are: (a) a/31 integrin (ot5/31) can exist in different affinity states; (b) the anti-~1 mAb 8A2 stimulates cell adhesion by converting the receptor from a low to a high affinity state; (c) this activation seems to be due to antibody-induced change in the receptor without intracellular signaling; and (d) the functional consequences of affinity modulation of the ot5/31 integrin depend on the ambient soluble fibronectin concentration.
The a5/31 integrin can manifest differing affinities for soluble fibronectin. The K562 cells (as well as the other nonadherent cell lines that we tested) bind soluble fibronectin with low affinity (Kd > 1 #M), but can be induced to bind it with 20-fold higher affinity (Kd = 54 riM). It is noteworthy that the fibronectin receptors on the adherent CHO and BHK cell lines have a measured affinity for soluble fibronectin that lies between these two values (1, 14) , implying that multiple affinity states exist. We have also found that soluble fibronectin binds to CHO cells with a similar affinity to that previously reported (Kd = 95 nM vs. 100 nM reported reference 14) (results not shown). This suggests that at plasma concentrations of fibronectin, high affinity receptors on adherent cells (e.g., fibroblasts) will be fully occupied. In contrast, ble fibronectin with higher affinity, which is a plausible basis for antibody enhancement of cellular adhesion to immobilized fibronectin. It is likely that the capacity of 8A2 to stimulate adhesion via other/31 integrins (32) is by the same mechanism. The 8A2-induced fibronectin binding has the appropriate characteristics for an integrin-ligand interaction, in that it is inhibited by the appropriate blocking antibodies as well as GRGDSP, and is dependent on the presence of divalent cations. The 8A2-induced increase in receptor affinity is due to a direct effect on the receptor that is apparently independent of intracellular signaling. We found that the increased binding of soluble fibronectin in the presence of 8A2 was unaffected by treating the cells with the metabolic inhibitors sodium azide and 2-deoxyglucose, even though the same treatment effectively inhibited the adhesion of these cells to immobilized fibronectin. In addition, the metabolically "poisoned" cells still had enhanced adhesion in the presence of increasing concentrations of 8A2. This suggests that directly increasing receptor affinity for its ligand will by itself produce a measurable increase in adhesion, but that maximal adhesion requires the participation of further events that are dependent on the generation of intracellular ATE e.g., cytoskeletal organization, focal contact formation, and cell spreading (11, 55). The fight correlation between fibronectin and 8A2 binding to the cells also suggests that the high affinity binding state of each receptor is directly dependent on an attached 8A2 molecule. Since the 8A2 Fab fragments bind with higher affinity to receptor that is occupied by the GRGDSP peptide ligand, the antibody may stabilize a high affinity (occupied) conformer of the receptor. Several activating anti-/33 mAbs also bind with higher affinity to the occupied form of c~IIbfl3, and have been termed anti-LIBS (ligand-induced binding sites) (19-21, 40) . Thus it may be that many activating anti-integrin antibodies are also anti-LIBS.
The functional consequences of affinity modulation of the c~5fll receptors depends on the ambient soluble fibronectin concentration. At physiological plasma concentrations of soluble fibronectin, a minority of the low affinity fibronectin receptors expressed by a cell will be occupied. In contrast, at the same concentration of fibronectin virtually all of the high affinity receptors will be occupied. For example, at the soluble fibronectin concentration of 675 nM that is used in the experiments summarized in Fig. 7 , the calculated fractional occupancy of the low affinity receptors is 36%, whereas the fractional occupancy of the high affinity receptors is calculated to be 93 %. Therefore, in the presence of saturating concentrations of 8A2, soluble fibronectin becomes a potent inhibitor of cellular adhesion to immobilized fibronectin by binding to the high affinity receptors. This "dualistic role" for fibronectin has been observed in cells which express moderate affinity fibronectin receptors (56). Hence, circulating leukocytes expressing low affinity receptors will retain their capacity to adherent to immobilized fibronectin that is laid down at sites of injury and during wound healing. In contrast, adherent cells express high affinity fibronectin receptors which could serve to bind soluble fibronectin from solution. This may be central to the involvement of u5/~l in the assembly of an extracellular fibronectin matrix (3, 18, 34, 48 ).
